Amrad to change its name
Tuesday, 20 September, 2005
Melbourne's Amrad Corporation (ASX:AML) will be seeking approval from shareholders to change its name.
The proposed name will be revealed on Monday, ahead of the company's AGM on October 27
"We've been through a process of trying to decide on an appropriate name for the company and we'll put it to the shareholders at the meeting," said Amrad CEO Andrew Nash.
Nash said the Amrad name had "history and legacy issues" and that changing the company's name was a way to move forward.
"Amrad has changed enormously in terms of its structure and the sort of things it works on. When I compare the Amrad now to the company that I started working with in 1996, it's completely different," said Nash. "We need to move on and changing the name is a symbolic part of that."
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
